169 related articles for article (PubMed ID: 34371129)
1. Landscape analysis of lncRNAs shows that DDX11-AS1 promotes cell-cycle progression in liver cancer through the PARP1/p53 axis.
Xu M; Zhao X; Zhao S; Yang Z; Yuan W; Han H; Zhang B; Zhou L; Zheng S; Li MD
Cancer Lett; 2021 Nov; 520():282-294. PubMed ID: 34371129
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
Li Y; Zhuang W; Huang M; Li X
Biochem Biophys Res Commun; 2019 Jul; 514(4):1051-1057. PubMed ID: 31097223
[TBL] [Abstract][Full Text] [Related]
3. LncRNA DDX11-AS1: a novel oncogene in human cancer.
Feng Y; Wu M; Hu S; Peng X; Chen F
Hum Cell; 2020 Oct; 33(4):946-953. PubMed ID: 32772230
[TBL] [Abstract][Full Text] [Related]
4. DDX11-AS1 as potential therapy targets for human hepatocellular carcinoma.
Shi M; Zhang XY; Yu H; Xiang SH; Xu L; Wei J; Wu Q; Jia R; Wang YG; Lu XJ
Oncotarget; 2017 Jul; 8(27):44195-44202. PubMed ID: 28496001
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.
Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P
Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis.
Ren Z; Liu X; Si Y; Yang D
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):572-583. PubMed ID: 32054332
[TBL] [Abstract][Full Text] [Related]
7. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
8. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
10. LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer.
Si X; Zhang G; Li M; Yao M; Shi X; Dong Z; Gao S
Pharmacology; 2023; 108(1):61-73. PubMed ID: 36382664
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DDX11-AS1 promotes cell growth, migration and invasion through regulating epithelial-mesenchymal transition in breast cancer.
Xi X; Yang F; Ding Z; Zhuang H; Yuan H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):40-44. PubMed ID: 38678629
[TBL] [Abstract][Full Text] [Related]
12. The long noncoding RNA
Qi H; Lu Y; Lv J; Wu H; Lu J; Zhang C; Zhang S; Bao Q; Zhang X; Xie C; Yin Z
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29776974
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
14. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
15. DDX11-AS1 contributes to osteosarcoma progression via stabilizing DDX11.
Zhang H; Lin J; Chen J; Gu W; Mao Y; Wang H; Zhang Y; Liu W
Life Sci; 2020 Aug; 254():117392. PubMed ID: 32014424
[TBL] [Abstract][Full Text] [Related]
16. Identification of The Aberrantly Expressed LncRNAs in Hepatocellular Carcinoma: A Bioinformatics Analysis Based on RNA-sequencing.
Liao HT; Huang JW; Lan T; Wang JJ; Zhu B; Yuan KF; Zeng Y
Sci Rep; 2018 Mar; 8(1):5395. PubMed ID: 29599483
[TBL] [Abstract][Full Text] [Related]
17. ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF.
Kong F; Deng X; Kong X; Du Y; Li L; Zhu H; Wang Y; Xie D; Guha S; Li Z; Guan M; Xie K
Oncogene; 2018 Nov; 37(45):5982-5996. PubMed ID: 29985481
[TBL] [Abstract][Full Text] [Related]
18. DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.
Li Q; Wang S; Wu Z; Liu Y
Biomed Pharmacother; 2020 Jul; 127():110164. PubMed ID: 32422563
[TBL] [Abstract][Full Text] [Related]
19. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA DDX11-AS1 promotes esophageal carcinoma cell proliferation and migration through regulating the miR-514b-3p/RBX1 axis.
Wu C; Wang Z; Tian X; Wang J; Zhang Y; Wu B
Bioengineered; 2021 Dec; 12(1):3772-3786. PubMed ID: 34281459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
